|

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

RECRUITINGPhase 3Sponsored by Sherief Abd-Elsalam
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2018-08-01
Est. completion2027-10
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03647072

Summary

The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* DLBCL Lymphoma subtype --No comorbid disease

Exclusion Criteria:

* Pregnancy
* Peptic ulcer
* Severe cardiac disease
* Osteoporosis

Conditions2

CancerLymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.